353 related articles for article (PubMed ID: 8647957)
1. Studies of the expression of the Wiskott-Aldrich syndrome protein.
Stewart DM; Treiber-Held S; Kurman CC; Facchetti F; Notarangelo LD; Nelson DL
J Clin Invest; 1996 Jun; 97(11):2627-34. PubMed ID: 8647957
[TBL] [Abstract][Full Text] [Related]
2. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
[TBL] [Abstract][Full Text] [Related]
3. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
Stewart DM; Tian L; Nelson DL
J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
[TBL] [Abstract][Full Text] [Related]
4. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.
Remold-O'Donnell E; Cooley J; Shcherbina A; Hagemann TL; Kwan SP; Kenney DM; Rosen FS
J Immunol; 1997 May; 158(9):4021-5. PubMed ID: 9126958
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.
Candotti F; Facchetti F; Blanzuoli L; Stewart DM; Nelson DL; Blaese RM
Gene Ther; 1999 Jun; 6(6):1170-4. PubMed ID: 10455421
[TBL] [Abstract][Full Text] [Related]
7. Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells.
Sato M; Iwaya R; Ogihara K; Sawahata R; Kitani H; Chiba J; Kurosawa Y; Sekikawa K
FEBS J; 2005 Dec; 272(23):6131-44. PubMed ID: 16302976
[TBL] [Abstract][Full Text] [Related]
8. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
Lemahieu V; Gastier JM; Francke U
Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
[TBL] [Abstract][Full Text] [Related]
10. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
Andreu N; Matamoros N; Escudero A; Fillat C
Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
[TBL] [Abstract][Full Text] [Related]
11. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.
Wada T; Konno A; Schurman SH; Garabedian EK; Anderson SM; Kirby M; Nelson DL; Candotti F
J Clin Invest; 2003 May; 111(9):1389-97. PubMed ID: 12727931
[TBL] [Abstract][Full Text] [Related]
12. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways.
Cory GO; MacCarthy-Morrogh L; Banin S; Gout I; Brickell PM; Levinsky RJ; Kinnon C; Lovering RC
J Immunol; 1996 Nov; 157(9):3791-5. PubMed ID: 8892607
[TBL] [Abstract][Full Text] [Related]
14. Wiskott-Aldrich syndrome (role of WASP).
Nonoyama S
J Med Dent Sci; 2001 Mar; 48(1):1-6. PubMed ID: 12160237
[TBL] [Abstract][Full Text] [Related]
15. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
16. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a deletion mutation involving exons 3-7 of the WASP gene detected in a patient with Wiskott-Aldrich syndrome.
Ariga T; Yamada M; Ito S; Iwamura M; Iseki M; Sakiyama Y
Hum Mutat; 1997; 10(4):310-6. PubMed ID: 9338585
[TBL] [Abstract][Full Text] [Related]
18. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
[TBL] [Abstract][Full Text] [Related]
19. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
20. The identification and characterization of two promoters and the complete genomic sequence for the Wiskott-Aldrich syndrome gene.
Hagemann TL; Kwan SP
Biochem Biophys Res Commun; 1999 Mar; 256(1):104-9. PubMed ID: 10066431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
